Inhibition of cyclin-dependent kinases is neuroprotective in 1-methyl-4-phenylpyridinium-induced apoptosis in neurons

Neuroscience

Volumn 146, Issue 1, 2007, Pages 350-365

  Alvira, D ^a   Tajes, M ^a   Verdaguer, E ^b   de Arriba, S García ^c   Allgaier, C ^c   Matute, C ^d   Trullas, R ^e   Jimenez A ^a   Pallas M ^a   Camins, A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c ACA   (Germany)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^e CSIC   (Spain)

Author keywords

apoptosis; cerebellar granule cells; cyclin dependent kinases; flavopiridol; vitamin E

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; ALPHA TOCOPHEROL; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; CELL CYCLE PROTEIN; CYCLIN D; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; FLAVOPIRIDOL; NEUROTOXIN; TRANSCRIPTION FACTOR E2F1;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CELL CYCLE; CELL VIABILITY; GRANULE CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

1-METHYL-4-PHENYLPYRIDINIUM; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CASPASES; CELL SURVIVAL; CELLS, CULTURED; CEREBELLUM; CYCLIN-DEPENDENT KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; E2F1 TRANSCRIPTION FACTOR; ENZYME INHIBITORS; FLOW CYTOMETRY; HERBICIDES; NEURONS; RATS; REACTIVE OXYGEN SPECIES; ROTENONE; TIME FACTORS;

EID: 34247490197     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.01.042     Document Type: Article

References (73)

1. Arendt T. Dysregulation of neuronal differentiation and cell cycle control in Alzheimer's disease. J Neural Transm Suppl 62 (2002) 77-85
2. Beal M.F. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment. J Bioenerg Biomembr 36 (2004) 381-386
3. Becker E.B., and Bonni A. Cell cycle regulation of neuronal apoptosis in development and disease. Progr Neurobiol 72 (2004) 1-25
4. Biswas S.C., Liu D.X., and Greene L.A. Bim is a direct target of a neuronal E2F-1 dependent apoptotic pathway. J Neurosci 25 (2005) 8349-8358
5. Bowser R., and Smith M.A. Cell cycle proteins in Alzheimer's disease: plenty of wheels but no cycle. J Alzheimer Dis 4 (2002) 249-254
6. Busser J., Geldmacher D.S., and Herrup K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J Neurosci 18 (1998) 2801-2807
7. Casadesus G., Atwood C.S., Zhu X., Hartzler A.W., Webber K.M., Perry G., Bowen R.L., and Smith M.A. Evidence for the role of gonadotropin hormones in the development of Alzheimer disease. Cell Mol Life Sci 62 (2005) 293-298
8. Cernak I., Stoica B., Byrnes K.R., Di Giovanni S., and Faden A.I. Role of the cell cycle in the pathobiology of central nervous system trauma. Cell Cycle 4 (2005) 1286-1293
9. +-induced cell death in dopaminergic neurons. Cell Mol Life Sci 62 (2005) 227-238
10. Choi W.S., Lee E.H., Chung C.W., Jung Y.K., Jin B.K., Kim S.U., Oh T.H., Saido T.C., and Oh Y.J. Cleavage of Bax is mediated by caspase-dependent or -independent calpain activation in dopaminergic neuronal cells: protective role of Bcl-2. J Neurochem 77 (2001) 1531-1541
11. Chu C.T., Zhu J.H., Cao G., Signore A., Wang S., and Chen J. Apoptosis inducing factor mediates caspase-independent 1-methyl-4-phenylpyridinium toxicity in dopaminergic cells. J Neurochem 94 (2005) 1685-1695
12. Cookson M.R. The biochemistry of Parkinson's disease. Annu Rev Biochem 74 (2005) 29-52
13. Copani A., Condorelli F., Canonico P.L., Nicoletti F., and Sortino M.A. Cell cycle progression towards Alzheimer's disease. Funct Neurol 16 (2001) 11-15
14. Copani A., Melchiorri D., Caricasole A., Martín F., Sale P., Carnevale R., Gradini R., Sortino M.A., Lenti L., De Maria R., and Nicoletti F. Beta-amyloid-induced synthesis of the ganglioside GD3 is a requisite for cell cycle reactivation and apoptosis in neurons. J Neurosci 22 (2002) 3963-3968
15. Copani A., Sortino M.A., Caricasole A., Chiechio S., Chisari M., Battaglia G., Giuffrida-Stella A.M., Vancheri C., and Nicoletti F. Erratic expression of DNA polymerases by beta-amyloid causes neuronal death. FASEB J 16 (2002) 2006-2008
16. Copani A., Uberti D., Sortino M.A., Bruno V., Nicoletti F., and Memo M. Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path?. Trends Neurosci 24 (2001) 25-31
17. Crocker S.J., Smith P.D., Jackson-Lewis V., Lamba W.R., Hayley S.P., Grimm E., Callaghan S.M., Slack R.S., Melloni E., Przedborski S., Robertson G.S., Anisman H., Merali Z., and Park D.S. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J Neurosci 23 (2003) 4081-4091
18. Di Giovanni S., Movsesyan V., Ahmed F., Cernak I., Schinelli S., Stoica B., and Faden A.I. Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury. Proc Natl Acad Sci U S A 102 (2005) 8333-8338
19. Dipasquale B., Marini A.M., and Youle R.J. Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons. Biochem Biophys Res Commun 181 (1991) 1442-1448
20. Dodel R.C., Du Y., Bales K.R., Ling Z., Carvey P.M., and Paul S.M. Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death. Mol Brain Res 64 (1999) 141-148
21. Du Y., Dodel R.C., Bales K.R., Jemmerson R., Hamilton-Byrd E., and Paul S.M. Involvement of a caspase-3-like cysteine protease in 1-methyl-4-phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons. J Neurochem 69 (1997) 1382-1388
22. Finiels-Marlier F., Marini A.M., Williams P., and Paul S.M. The N-methyl-D-aspartate antagonist MK-801 fails to protect dopaminergic neurons from 1-methyl-4-phenylpyridinium toxicity in vitro. J Neurochem 60 (1993) 1968-1971
23. Frade J.M. Unscheduled reentry into the cell cycle induced by NGF precedes cell death in nascent retinal neurones. J Cell Sci 113 (2000) 1139-1148
24. Giovanni A., Wirtz-Brugger F., Keramaris E., Slack R., and Park D.S. Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F x DP, in B-amyloid-induced neuronal death. J Biol Chem 274 (1999) 19011-19016
25. + incorporation into cerebellar granule cells. Brain Res Bull 56 (2001) 119-123
26. + causes inhibition of cellular energy supply in cerebellar granule cells. Neurotoxicology 24 (2003) 219-225
27. +) in cerebellar granule cells. J Neurochem 84 (2003) 305-315
28. +: mechanism for its toxicity in cerebellar granule cells. Mol Neurobiol 30 (2004) 253-264
29. + neurotoxicity in cerebellar granule cells by antioxidants. Cell Biol Int 28 (2004) 373-380
30. Herrup K., and Arendt T. Re-expression of cell cycle proteins induces neuronal cell death during Alzheimer's disease. J Alzheimers Dis 4 (2002) 243-247
31. Herrup K., Neve R., Ackerman S.L., and Copani A. Divide and die: cell cycle events as triggers of nerve cell death. J Neurosci 24 (2004) 9232-9239
32. Hou S.T., Callaghan D., Fournier M.C., Hill I., Kang L., and Massie B. The transcription factor E2F1 modulates apoptosis of neurons. J Neurochem 75 (2000) 91-100
33. Hou S.T., Cowan E., Walker T., Ohan N., Dove M., Rasqinha I., and MacManus J.P. The transcription factor E2F1 promotes dopamine-evoked neuronal apoptosis by a mechanism independent of transcriptional activation. J Neurochem 78 (2001) 287-297
34. Jordan-Sciutto K.L., Dorsey R., Chalovic E.M., Hammond R.R., and Achim C.L. Expression patterns of retinoblastoma protein in Parkinson disease. J Neuropathol Exp Neurol 62 (2003) 68-74
35. Jordan-Sciutto K.L., Malaiyandi L.M., and Bowser R. Altered distribution of cell cycle transcriptional regulators during Alzheimer disease. J Neuropathol Exp Neurol 61 (2002) 358-367
36. Klein J.A., Longo-Guess C.M., Rossmann M.P., Seburn K.L., Hurd R.E., and Frankel W.N. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 419 (2002) 367-374
37. Kruman I.I. Why do neurons enter the cell cycle?. Cell Cycle 3 (2004) e56-e60
38. Langley B., and Ratan R.R. Oxidative stress-induced death in the nervous system: cell cycle dependent or independent?. J Neurosci Res 77 (2004) 621-629
39. Lang-Rollin I.C., Rideout H.J., Noticewala M., and Stefanis L. Mechanisms of caspase-independent neuronal death: energy depletion and free radical generation. J Neurosci 23 (2003) 11015-11025
40. Leist M., Volbracht C., Fava E., and Nicotera P. 1-Methyl-4-phenylpyridinium induces autocrine excitotoxicity, protease activation, and neuronal apoptosis. Mol Pharmacol 54 (1998) 789-801
41. Liou A.K., Zhou Z., Pei W., Lim T.M., Yin X.M., and Chen J. BimEL up-regulation potentiates AIF translocation and cell death in response to MPTP. FASEB J 19 (2005) 1350-1352
42. Maas Jr. J.W., Horstmann S., Borasio G.D., Anneser J.M., Shooter E.M., and Kahle P.J. Apoptosis of central and peripheral neurons can be prevented with cyclin-dependent kinase/mitogen-activated protein kinase inhibitors. J Neurochem 70 (1998) 1401-1410
43. Marini A.M., and Paul S.M. N-methyl-D-aspartate receptor-mediated neuroprotection in cerebellar granule cells requires new RNA and protein synthesis. Proc Natl Acad Sci U S A 89 (1992) 6555-6559
44. Mirjany M., Ho L., and Pasinetti G.M. Role of cyclooxygenase-2 in neuronal cell cycle activity and glutamate-mediated excitotoxicity. J Pharmacol Exp Ther 301 (2002) 494-500
45. Moore D.J., West A.B., Dawson V.L., and Dawson T.M. Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci 28 (2005) 57-87
46. Motonaga K., Itoh M., Hirayama A., Hirano S., Becker L.E., Goto Y., and Takashima S. Up-regulation of E2F-1 in Down's syndrome brain exhibiting neuropathological features of Alzheimer-type dementia. Brain Res 905 (2001) 250-253
47. Nagy Z., Esiri M.M., and Smith A.D. Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol (Berl) 93 (1997) 294-300
48. Nguyen M.D., and Julián J.P. Cyclin-dependent kinase 5 in amyotrophic lateral sclerosis. Neurosignals 12 (2003) 215-220
49. Pallàs M., Verdaguer E., Jorda E.G., Jiménez A., Canudas A.M., and Camins A. Flavopiridol: an antitumor drug with potential application in the treatment of neurodegenerative diseases. Med Hypotheses 64 (2005) 120-123
50. Phillips A.C., and Vousden K.H. E2F-1 induced apoptosis. Apoptosis 6 (2001) 173-183
51. Polster B.M., Basanez G., Etxebarria A., Hardwick J.M., and Nicholls D.G. Calpain I induces cleavage and release of apoptosis-inducing factor from isolated mitochondria. J Biol Chem 280 (2005) 6447-6454
52. Raina A.K., Pardo P., Rottkamp C.A., Zhu X., Pereira-Smith O.M., and Smith M.A. Neurons in Alzheimer disease emerge from senescence. Mech Ageing Dev 123 (2001) 3-9
53. Raina A.K., Zhu X., and Smith M.A. Alzheimer's disease and the cell cycle. Acta Neurobiol Exp (Wars) 64 (2004) 107-112
54. Ranganathan S., and Bowser R. Alterations in G (1) to S phase cell-cycle regulators during amyotrophic lateral sclerosis. Am J Pathol 162 (2003) 823-835
55. Shang T., Kotamraju S., Kalivendi S.V., Hillard C.J., and Kalyanaraman B. 1-Methyl-4-phenylpyridinium-induced apoptosis in cerebellar granule neurons is mediated by transferrin receptor iron-dependent depletion of tetrahydrobiopterin and neuronal nitric-oxide synthase-derived superoxide. J Biol Chem 279 (2004) 19099-19112
56. Shang T., Uihlein A.V., Van Asten J., Kalyanaraman B., and Hillard C.J. 1-Methyl-4-phenylpyridinium accumulates in cerebellar granule neurons via organic cation transporter 3. J Neurochem 85 (2003) 358-367
57. Shapiro G.I. Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridol. Clin Cancer Res 10 (2004) 4270s-4275s
58. Smith P.D., Crocker S.J., Jackson-Lewis V., Jordan-Sciutto K.L., Hayley S., Mount M.P., O'Hare M.J., Callaghan S., Slack R.S., Przedborski S., Anisman H., and Park D.S. Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A 100 (2003) 13650-13655
59. Smith P.D., O'Hare M.J., and Park D.S. CDKs: taking on a role as mediators of dopaminergic loss in Parkinson's disease. Trends Mol Med 10 (2004) 445-451
60. Smith R.A., Walker T., Xie X., and Hou S.T. Involvement of the transcription factor E2F1/Rb in kainic acid-induced death of murine cerebellar granule cells. Mol Brain Res 116 (2003) 70-79
61. Stefanis L. Caspase-dependent and -independent neuronal death: two distinct pathways to neuronal injury. Neuroscientist 11 (2005) 50-62
62. Stevens C., and La Thangue N.B. E2F and cell cycle control: a double-edged sword. Arch Biochem Biophys 412 (2003) 157-169
63. Stevens C., and La Thangue N.B. The emerging role of E2F-1 in the DNA damage response and checkpoint control. DNA Repair 3 (2004) 1071-1079
64. Tretter L., Sipos I., and Adam-Vizzi V. Initiation of neuronal damage by complex I deficiency and oxidative stress in Parkinson's disease. Neurochem Res 29 (2004) 569-577
65. Verdaguer E., Garcia-Jorda E., Canudas A.M., Dominguez E., Jimenez A., Pubill D., Escubedo E., Camarasa J., Pallàs M., and Camins A. Kainic acid-induced apoptosis in cerebellar granule neurons: an attempt at cell cycle reentry. Neuroreport 13 (2002) 413-416
66. Verdaguer E., Jimenez A., Canudas A.M., Jorda E.G., Sureda F.X., Pallàs M., and Camins A. Inhibition of cell cycle pathway by flavopiridol promotes survival of cerebellar granule cells after an excitotoxic treatment. J Pharmacol Exp Ther 308 (2004) 609-616
67. Volbracht C., Leist M., Kolb S.A., and Nicotera P. Apoptosis in caspase-inhibited neurons. Mol Med 7 (2001) 36-48
68. Wang F., Corbett D., Osuga H., Osuga S., Ikeda J.E., Slack R.S., Hogan M.J., Hakim A.M., and Park D.S. Inhibition of cyclin-dependent kinases improves CA1 neuronal survival and behavioral performance after global ischemia in the rat. J Cereb Blood Flow Metab 22 (2002) 171-182
69. Webber K.M., Raina A.K., Marlatt M.W., Zhu X., Prat M.I., Morelli L., Casadesus G., Perry G., and Smith M.A. The cell cycle in Alzheimer disease: A unique target for neuropharmacology. Mech Ageing Dev 126 (2005) 1019-1025
70. Wu C.R., Zhang Y., Rose M.E., and Graham S.H. Cyclooxygenase-2 activity contributes to neuronal expression of cyclin D1 after anoxia/ischemia in vitro and in vivo. Mol Brain Res 132 (2004) 31-37
71. Yang Y., Geldmacher D.S., and Herrup K. DNA replication precedes neuronal cell death in Alzheimer's disease. J Neurosci 21 (2001) 2661-2668
72. Yang Y., Mufson E.J., and Herrup K. Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease. J Neurosci 23 (2003) 2557-2563
73. Zhu X., Raina A.K., Perry G., and Smith M.A. Alzheimer's disease: the two-hit hypothesis. Lancet 3 (2004) 219-226